Company profile VYGR
After 39 days of this quarter the interest is at 174.0. Based on that we can calculate that during remaining 52 days it will total up to 406.0. That appears to be equal to previous quarter and same quarter last year.
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 304 | 432 42.1% QoQ | 309 -28.5% QoQ | 296 -4.2% QoQ |
| 2020 | 370 21.7% YoY 25.0% QoQ | 301 -30.3% YoY -18.6% QoQ | 349 12.9% YoY 15.9% QoQ | 286 -3.4% YoY -18.1% QoQ |
| 2021 | 316 -14.6% YoY 10.5% QoQ | 286 -5.0% YoY -9.5% QoQ | 176 -49.6% YoY -38.5% QoQ | 329 15.0% YoY 86.9% QoQ |
| 2022 | 451 42.7% YoY 37.1% QoQ | 355 24.1% YoY -21.3% QoQ | 230 30.7% YoY -35.2% QoQ | 166 -49.5% YoY -27.8% QoQ |
| 2023 | 460 2.0% YoY 177.1% QoQ | 313 -11.8% YoY -32.0% QoQ | 151 -34.3% YoY -51.8% QoQ | 301 81.3% YoY 99.3% QoQ |
| 2024 | 174 -62.2% YoY -42.2% QoQ | - | - | - |
The average 5 years interest of Voyager Therapeutics was 24.35 per week. The last year interest of Voyager Therapeutics compared to the last 5 years has changed by -8.87%. The interest for Voyager Therapeutics is seasonal. The last year interest is quite lower compared to 5 years ago. It has decreased by -21.67%.
There is not enough data for Voyager Therapeutics Cambridge to provide analysis
There is not enough data for Voyager Therapeutics Cambridge to provide correlation calculation
There is not enough data for Voyager Therapeutics Cambridge to provide analysis
After 39 days of this quarter the interest is at 60.0. Based on that we can calculate that during remaining 52 days it will total up to 140.0. That appears to be equal to previous quarter and same quarter last year.
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 142 | 0 -100.0% QoQ | 217 inf% QoQ | 52 -76.0% QoQ |
| 2020 | 183 28.9% YoY 251.9% QoQ | 171 inf% YoY -6.6% QoQ | 104 -52.1% YoY -39.2% QoQ | 82 57.7% YoY -21.2% QoQ |
| 2021 | 185 1.1% YoY 125.6% QoQ | 77 -55.0% YoY -58.4% QoQ | 190 82.7% YoY 146.8% QoQ | 135 64.6% YoY -28.9% QoQ |
| 2022 | 404 118.4% YoY 199.3% QoQ | 264 242.9% YoY -34.7% QoQ | 89 -53.2% YoY -66.3% QoQ | 68 -49.6% YoY -23.6% QoQ |
| 2023 | 205 -49.3% YoY 201.5% QoQ | 89 -66.3% YoY -56.6% QoQ | 0 -100.0% YoY -100.0% QoQ | 147 116.2% YoY inf% QoQ |
| 2024 | 60 -70.7% YoY -59.2% QoQ | - | - | - |
The average 5 years interest of Voyager Therapeutics Stock was 10.97 per week. The last year interest of Voyager Therapeutics Stock compared to the last 5 years has changed by -31.08%. This is something to be checked. The last year interest is quite lower compared to 5 years ago. It has decreased by -23.09%.
There is not enough data for Voyager Therapeutics Neurology to provide analysis
There is not enough data for Voyager Therapeutics Neurology to provide correlation calculation
There is not enough data for Voyager Therapeutics Neurology to provide analysis
There is not enough data for VY-TAU01 to provide analysis
There is not enough data for VY-TAU01 to provide correlation calculation
There is not enough data for VY-TAU01 to provide analysis
There is not enough data for Voyager Therapeutics Alzheimer's disease to provide analysis
There is not enough data for Voyager Therapeutics Alzheimer's disease to provide correlation calculation
There is not enough data for Voyager Therapeutics Alzheimer's disease to provide analysis
There is not enough data for Voyager Therapeutics Friedreich's ataxia to provide analysis
There is not enough data for Voyager Therapeutics Friedreich's ataxia to provide correlation calculation
There is not enough data for Voyager Therapeutics Friedreich's ataxia to provide analysis
There is not enough data for Voyager Therapeutics Parkinson's disease to provide analysis
There is not enough data for Voyager Therapeutics Parkinson's disease to provide correlation calculation
There is not enough data for Voyager Therapeutics Parkinson's disease to provide analysis
There is not enough data for Voyager Therapeutics Huntington's disease to provide analysis
There is not enough data for Voyager Therapeutics Huntington's disease to provide correlation calculation
There is not enough data for Voyager Therapeutics Huntington's disease to provide analysis
There is not enough data for Voyager Therapeutics Gene Therapy to provide analysis
There is not enough data for Voyager Therapeutics Gene Therapy to provide correlation calculation
There is not enough data for Voyager Therapeutics Gene Therapy to provide analysis